Pharmacological modulation of anti-tumor immunity induced by oncolytic viruses
Oncolytic viruses kill cancer cells by direct lysis but also generate a significant anti-tumor immune response that allows for prolonged cancer control and in some cases cures. How to best stimulate this effect is a subject of intense investigation in the oncolytic virus field. While pharmacological...
Main Authors: | Nicole E. Forbes, Ramya eKrishnan, Jean-Simon eDiallo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00191/full |
Similar Items
-
Exploiting tumor epigenetics to improve oncolytic virotherapy
by: Nicole E. Forbes, et al.
Published: (2013-09-01) -
Oncolytic Viruses: Newest Frontier for Cancer Immunotherapy
by: Masmudur M. Rahman, et al.
Published: (2021-10-01) -
Chemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer
by: Andrew eNguyen, et al.
Published: (2014-06-01) -
Recent advances in oncolytic virus therapy for hepatocellular carcinoma
by: Licheng Zhu, et al.
Published: (2023-04-01) -
The Continued Promise and Many Disappointments of Oncolytic Virotherapy in Gastrointestinal Malignancies
by: Daniel H. Ahn, et al.
Published: (2017-03-01)